FT Big Read

Fighting cancer: Rocky path for immunotherapy

13:56 | Feb 10th, 2017

High hopes that new immunotherapy drugs would prove to have benefits over toxic chemotherapy were dashed by large-scale trials, says David Crow. Pharmaceutical groups are now working on combinations of the immunotherapies and using them with chemo, b...Show More